Editor's Note The US Food and Drug Administration (FDA) has designated the recall of Hologic Inc.’s BioZorb Marker a class 1, indicating a risk of serious injury or death. BioZorb is an implantable radiographic marker used to mark soft tissue (such as breast tissue) for future medical procedures. Provided sterile…

Read More

Editor's Note The largest scale analysis so far available comparing surgical aortic valve replacement (SAVR) to longer-term percutaneous devices for transcatheter aortic valve replacement (TAVR) supports the comparable long-term safety and efficacy of the latter procedure. According to a May 15 report in Medical Xpress, the findings raise important considerations for valve…

Read More

Editor's Note A joint letter from the American Medical Association (AMA) and more than 100 medical organizations asks Health and Human Services (HHS) Secretary Xavier Becerra to confirm that providers do not bear responsibility for legal reporting requirements for information stolen in the Change Healthcare cyberattack, including personal patient data.…

Read More

Editor's Note Only 46% of parents and 33% of teenagers believe receiving the latest COVID-19 vaccine was important, according to survey results presented by at a May 2-6 Pediatric Academic Societies Meeting in Toronto, Canada.   According to a May 9 Helio report on the findings, the survey is the…

Read More

Editor's Note A $50 million initiative to develop cybersecurity tools for hospitals aims to protect providers and patients alike from ransomware, according to a May 20 report in Becker’s Health IT. The Universal PatchinG and Remediation for Autonomous DEfense, or UPGRADE, program was launched the same day by the Advanced Research…

Read More

Editor's Note Popular weight-loss \ drug semaglutide could significantly increase risk for repeat operations patients with diabetes who undergo lumbar surgery. According to a May 8 report in Medscape Medical News, the findings are pending review for publication and reportedly provides the first evidence on the impact of semaglutide on…

Read More

Editor's Note Building on previous evidence favoring thrombectomy even in high-risk cases, the prospective randomized LASTE trial finds the surgical procedure could reduce mortality and improve funcational outcomes in patients with acute stroke and large infarct of unrestricted size. Medpage Today reported the news May 8. Originally published in the…

Read More

Editor's Note Nine out of 10 American adults have Cardiovascular, kidney, and metabolic syndrome (CKM)—interrelated factors that progress to heart disease—and almost 10% already have heart disease, according to a report published in JAMA by Brigham and Women’s Hospital and Harvard Medical School in Boston. HealthDay news reported on the…

Read More

Editor's Note The US Food and Drug Administration (FDA) has classified recalls of Abbot’s HeartMate 3 Left Ventricular Assist System (LVAS) implant kits and Phillips Respironics' Trilogy Evo ventilators as class 1, the most serious category indicating risk of serious injury or death. Used while waiting for recovery, a transplant,…

Read More

Editor's Note According to the annual Sentinel Event Data Report, The Joint Commission received 1,411 reports of sentinel events—an event not related to the natural course of an illness or condition that causes severe harm, permanent harm or death—in 2023. Of that total, 96% of events were voluntary self-reported by…

Read More